Single-cell RNA sequencing and transcriptome analyses have demonstrated that CKI enhances immune cell infiltration into the tumor microenvironment, particularly increasing CD8+ T cell activation and NK cell cytotoxicity (Liu et al., 2022; Liu et al., 2021). The gene discussed is CD8A; the disease is neoplasm.